PFS
TWST icon

Prospera Financial Services’s Twist Bioscience TWST Stock Holding History

Prospera Financial Services’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-50
Closed -$2K – 2550
2022
Q1 		$2K Buy
+50
New +$2.77K ﹤0.01% 2523

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Prospera Financial Services's TWST Position: Q2 2022 in Review

Prospera Financial Services sold out of Twist Bioscience (TWST) in Q2 2022, closing a stake of 50 shares — an estimated $2K sold.

Prospera Financial Services first reported a position in TWST in Q1 2022 and held it in 1 quarter. The position peaked at $2K in Q1 2022. 203 funds tracked by Wall St. Rank hold TWST as of Q2 2022.

  • Prospera Financial Services reported no remaining Twist Bioscience position as of Q2 2022 after selling out during the quarter.
  • Prospera Financial Services sold 50 Twist Bioscience shares in Q2 2022, an estimated $2K.
  • Prospera Financial Services first reported a position in Twist Bioscience in Q1 2022 and held it in 1 quarter.
  • Prospera Financial Services's Twist Bioscience position peaked at $2K in Q1 2022.
  • 203 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2022.

Based on Prospera Financial Services's 13F filing for Q2 2022, filed 8 Aug 2022.